Enoxaparin and unfractionated heparin in acute coronary syndromes without ST-segment elevation

被引：0
作者：
Cohen, M
Antman, EM
机构：
[1] Med Coll Penn & Hahnemann Univ, Sch Med, Div Cardiol, Philadelphia, PA 19102 USA
[2] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA
来源：
THROMBOSIS AND HAEMOSTASIS | 2002年 / 88卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：884 / 886
页数：3
相关论文
共 18 条
[1]   Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction - Results of the thrombolysis in myocardial infarction (TIMI) 11B trial [J].
Antman, EM ;
McCabe, CH ;
Gurfinkel, EP ;
Turpie, AGG ;
Bernink, PJLM ;
Salein, D ;
de Luna, AB ;
Fox, K ;
Lablanche, JM ;
Radley, D ;
Premmereur, J ;
Braunwald, E .
CIRCULATION, 1999, 100 (15) :1593-1601
[2]   Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction - TIMI 11B-ESSENCE meta-analysis [J].
Antman, EM ;
Cohen, M ;
Radley, D ;
McCabe, C ;
Rush, J ;
Premmereur, J ;
Braunwald, E .
CIRCULATION, 1999, 100 (15) :1602-1608
[3]   Hirudin in acute myocardial infarction - Thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial [J].
Antman, EM .
CIRCULATION, 1996, 94 (05) :911-921
[4]   Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE [J].
Antman, EM ;
Cohen, M ;
McCabe, C ;
Goodman, SG ;
Murphy, SA ;
Braunwald, E .
EUROPEAN HEART JOURNAL, 2002, 23 (04) :308-314
[5]  
Borja J, 2002, THROMB HAEMOSTASIS, V87, P538
[6]   Superiority of enoxaparin versus unfractionated heparin for unstable angina/non-Q-wave myocardial infarction regardless of activated partial thromboplastin time [J].
Bozovich, GE ;
Gurfinkel, EP ;
Antman, EM ;
McCabe, CH ;
Mautner, B .
AMERICAN HEART JOURNAL, 2000, 140 (04) :637-642
[7]   ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction [J].
Braunwald, E ;
Antman, EM ;
Beasley, JW ;
Califf, RM ;
Cheitlin, MD ;
Hochman, JS ;
Jones, RH ;
Kereiakes, D ;
Kupersmith, J ;
Levin, TN ;
Pepine, CJ ;
Schaeffer, JW ;
Smith, EE ;
Steward, DE ;
Theroux, P ;
Gibbons, RJ ;
Alpert, JS ;
Eagle, KA ;
Faxon, DP ;
Fuster, V ;
Gardner, TJ ;
Gregoratos, G ;
Russell, RO ;
Smith, SC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :970-1056
[8]   A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease [J].
Cohen, M ;
Demers, C ;
Gurfinkel, EP ;
Turpie, AGG ;
Fromell, GJ ;
Goodman, S ;
Langer, A ;
Califf, RM ;
Fox, KAA ;
Premmereur, J ;
Bigonzi, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (07) :447-452
[9]  
Guerrero RAA, 1999, EUR HEART J, V20, P1553
[10]   Thrombotic reactant markers in non-ST segment elevation acute coronary syndromes treated with either enoxaparin (low molecular weight heparin) or unfractionated heparin [J].
Gurfinkel, E ;
Duronto, E ;
Colorio, C ;
Bozovich, G ;
Cohen, M ;
Mautner, B .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 1999, 8 (03) :227-232
12